Wellness Hims & Hers Stands to Gain If the FDA Loosens Restrictions on Peptides Amina Niasse Published: July 23, 2026 Share on Facebook Share on Twitter Share via Email Credit: REUTERS/Carlo Allegri/File Photo A U.S. Food and Drug Administration advisory committee meets this week to discuss whether the regulator should loosen compounding restrictions on seven peptides REUTERS — Hims… Membership Required This article is for ATN Pro members only. Subscribe Now Already a member? Log in Already a member? Log in here Tags:ATN Pro FDA Hims & Hers peptides
